Announcement
Super Grannies and Market Update – June 30 Webinar Cancelled

COVID-19 UPDATE: Moderna trial results suggest vaccine here much sooner. Looking at 1Q2020, March monthly EPS was likely $5.50 (vs $14 Jan/Feb). Revising 2020 S&P 500 EPS to $50 ($110 prior) but keeping 2021 at $193.

COVID-19 remains a global crisis and we realize that many people need to keep up with COVID-19 developments, particularly since we are moving into the more critical stage ("restart economy"), so feel free to share our commentary to anyone who has interest.There were two notable positive developments in this COVID-19 crisis today.  First, is the Moderna announcement of the initial success of its mRNA trial, with the first 8 recipients of the vaccine showing high levels of antibodies, enough ...

Finish reading this report for free

Enter your email and we’ll send the paywall-free link directly to your inbox

In addition to your unlocked report, you will receive our weekly market newsletter FSI Snapshot, as well as occasional updates and offers from FS Insight. You can unsubscribe at any time. For more information, see our privacy policy.

Get unlimited access to Tom Lee’s Fundstrat research Subscribe
Already a member? Log in

More from the author

Disclosures (show)

Get invaluable analysis of the market and stocks. Cancel at any time. Start Free Trial

Articles Read 2/2

🎁 Unlock 1 extra article by joining our Community!

You are reading the last free article for this month.

By continuing, you agree to the Terms of Service and Privacy Policy.

Already have an account? Sign In

Trending tickers in our research

Get invaluable analysis of the market and stocks. Cancel at any time. Start Free Trial

Articles Read 2/2

🎁 Unlock 1 extra article by joining our Community!

You are reading the last free article for this month.

By continuing, you agree to the Terms of Service and Privacy Policy.

Already have an account? Sign In